Evaluation of Lines of Therapy Amongst Patients with NSCLC Tested with a Host Immune Classifier (HIC) in a Real-World Setting

被引：0
|
作者：
Iams, Wade [1 ]
Le, Kimberly [2 ]
Princic, Nicole [3 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Biodesix Inc, Boulder, CO USA
[3] Merative, Ann Arbor, MI USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PP01.16
引用
收藏
页码：E14 / E15
页数：2
相关论文
共 50 条
  • [1] Healthcare Utilization Amongst Patients with NSCLC Before and After Testing with a Host Immune Classifier (HIC) in a Real-World Setting
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E13 - E14
  • [2] Real-world healthcare costs amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)
    Iams, Wade Thomas
    Le, Kimberly
    Princic, Nicole
    Marlin, Taylor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Real-world healthcare resource utilization amongst non-small cell lung cancer (NSCLC) patients tested with a host immune classifier (HIC)
    Iams, Wade Thomas
    Le, Kimberly
    Princic, Nicole
    Marlin, Taylor
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [4] Real-world demographics, baseline characteristics, healthcare resource utilization and costs amongst non-small cell lung cancer (NSCLC) patients tested with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    Winer, Isabelle
    Marlin, Taylor
    CANCER RESEARCH, 2023, 83 (07)
  • [5] Healthcare Utilization Amongst Patients with NSCLC Stratified by Metastatic Status Before and After Testing with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E14
  • [6] Outcomes of Anlotinib Maintenance Therapy in Patients With Advanced NSCLC in a Real-World Setting
    Li, Jia
    Han, Baohui
    Liu, Huaimin
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [7] Healthcare Costs Amongst Patients with Non-Small Cell lung cancer (NSCLC) Before and After Testing with a Host Immune Classifier (HIC)
    Iams, Wade
    Le, Kimberly
    Princic, Nicole
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (07) : E14 - E14
  • [8] Efficacy of Atezolizumab in Subsequent Lines of Therapy for NSCLC Patients: Insights from Real-World Data
    Kontic, Milica
    Markovic, Filip
    Nikolic, Nikola
    Samardzic, Natalija
    Stojanovic, Goran
    Simurdic, Petar
    Petkov, Svetlana
    Bursac, Daliborka
    Zaric, Bojan
    Stjepanovic, Mihailo
    CANCERS, 2024, 16 (21)
  • [9] Comprehensive analysis of MET mutations in NSCLC patients in a real-world setting
    Ai, Xinghao
    Yu, Yongfeng
    Zhao, Jun
    Sheng, Wang
    Bai, Jing
    Fan, Zaiwen
    Liu, Xuemei
    Ji, Wenxiang
    Chen, Rongrong
    Lu, Shun
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
  • [10] Treatment patterns, duration and outcomes of pemetrexed maintenance therapy in patients with advanced NSCLC in a real-world setting
    Winfree, Katherine B.
    Torres, Aracelis Z.
    Zhu, Yajun Emily
    Muehlenbein, Catherine
    Aggarwal, Himani
    Woods, Susan
    Abernethy, Amy
    CURRENT MEDICAL RESEARCH AND OPINION, 2019, 35 (05) : 817 - 827
12345